Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-Specific vs Standard Pain Protocols in SCD
NCT02222246Phase 4Completed
- Sponsor
- Duke University
- Start
- Mar 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of morphine, hydromorphone in sickle cell disease (SCD), sponsored by Duke University. Started Mar 2015; status: completed.
02
Drugs
morphinehydromorphone
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02222246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222246.